1 – How many Ovarian Carcinoma patients (any stage) have been diagnosed in the last 12 months?
2 – How many stage III or IV Ovarian Carcinoma patients have received Chemotherapy for the first time in the last 12 months?
Of these how many patients are on Platinum based therapy (Monotherapy or combination therapy)?
3 – How many stage III or IV Ovarian Carcinoma patients have been diagnosed as Platinum refractory (i.e. progression of disease whilst receiving Platinum therapy) or resistant (i.e. progression of disease within 6 months of last Platinum dose) in the last 12 months?
4 – How many patients with Stage III or IV Ovarian Carcinoma have been treated with the following treatments in the last 12 months?
5 – Within your Trust how many patients with Advanced Prostate Cancer have been treated in the past 12 months with the following treatments?
6 – How many patients being treated with Abiraterone or Enzalutamide and have been on this treatment for more than 1 year?

Download response Ovarian and Prostate treatments. 010318